Get started
Author

Birsen Can Demirdöğen

Observed names: B Can Demirdöğen, B. Can Demirdöğen, B.C. Demirdogen, Birsen CAN DEMİRDÖĞEN, Birsen Can Demirdogen, Birsen Can Demirdöğen, Birsen Demirdöğen, Demirdöğen, Birsen Can, Demirdöğen, Birsen Can
ORCID: 0000-0002-1536-6123
Observed ORCID: 0000-0002-1536-6123
OpenAlex ID: A5038019952
Biomarkers of NRF2 signalling: Current status and future challenges
2024 · Christina Morgenstern, Isabel Lastres-Becker, et al. · Redox Biology · 180
Gliovascular transcriptional perturbations in Alzheimer’s disease reveal molecular mechanisms of blood brain barrier dysfunction
2024 · Özkan İş, Xue Wang, et al. · Nature Communications · 59
Paraoxonase/arylesterase ratio, PON1 192Q/R polymorphism and PON1 status are associated with increased risk of ischemic stroke
2007 · Birsen Can Demirdöğen, Aysun Türkanoğlu, et al. · Clinical Biochemistry · 57
In vivo evaluation of the effects of hydraulic calcium silicate dental cements on plasma and liver aluminium levels in rats
2015 · Kadriye Demirkaya, Birsen Can Demirdöğen, et al. · European Journal Of Oral Sciences · 46
Association analysis of GSTT1, GSTM1 genotype polymorphisms and serum total GST activity with ischemic stroke risk
2010 · Aysun Türkanoğlu, Birsen Can Demirdöğen, et al. · Neurological Sciences · 43
Evaluation of Essential and Toxic Trace Elements in Pseudoexfoliation Syndrome and Pseudoexfoliation Glaucoma
2013 · Osman Melih Ceylan, Birsen Can Demirdöğen, et al. · Biological Trace Element Research · 35
Analysis of paraoxonase 1 (PON1) genetic polymorphisms and activities as risk factors for ischemic stroke in Turkish population
2009 · Birsen Can Demirdöğen, Şeref Demirkaya, et al. · Cell Biochemistry and Function · 33
Brain aluminium accumulation and oxidative stress in the presence of calcium silicate dental cements
2016 · K Demirkaya, B Can Demirdöğen, et al. · Human & Experimental Toxicology · 30
Evaluation of Oxidative Stress and Paraoxonase Phenotypes in Pseudoexfoliation Syndrome and Pseudoexfoliation Glaucoma
2013 · Birsen Demirdöğen, Osman Ceylan, et al. · Clinical Laboratory · 28
Altered NRF2 signalling in systemic redox imbalance: Insights from non-communicable diseases
2025 · Monika Jakubowska, Vera Marisa Costa, et al. · Redox Biology · 23
A literature review of biosensors for multiple sclerosis: Towards personalized medicine and point-of-care testing
2020 · Birsen Can Demirdöğen · Multiple Sclerosis and Related Disorders · 23
Evaluation of Tear Fluid and Aqueous Humor Concentration of Clusterin as Biomarkers for Early Diagnosis of Pseudoexfoliation Syndrome and Pseudoexfoliative Glaucoma
2019 · Birsen Can Demirdöğen, Sinem Demirkaya-Budak, et al. · Current Eye Research · 21
Apolipoprotein A5 polymorphisms in Turkish population: association with serum lipid profile and risk of ischemic stroke
2012 · Birsen Can Demirdöğen, Esra Şahin, et al. · Molecular Biology Reports · 19
Missense Genetic Polymorphisms of Microsomal (EPHX1) and Soluble Epoxide Hydrolase (EPHX2) and Their Relation to the Risk of Large Artery Atherosclerotic Ischemic Stroke in a Turkish Population
2021 · Birsen Can Demirdöğen, Yağmur Miçooğulları, et al. · Neuropsychiatric Disease and Treatment · 16
PDF
Evaluation of tear and aqueous humor level, and genetic variants of connective tissue growth factor as biomarkers for early detection of pseudoexfoliation syndrome/glaucoma
2019 · Birsen Can Demirdöğen, Canan Koçan Akçin, et al. · Experimental Eye Research · 16
Flavin containing monooxygenase 3 genetic polymorphisms Glu158Lys and Glu308Gly and their relation to ischemic stroke
2013 · Aysun Türkanoğlu Özçelik, Birsen Can Demirdöğen, et al. · Gene · 16
Cytochrome P4501A1 genotypes and smoking- and hypertension-related ischemic stroke risk
2012 · B. Can Demirdöğen, A.Ç. Adali, et al. · Human & Experimental Toxicology · 15
Genetic polymorphisms of vitamin D3 metabolizing CYP24A1 and CYP2R1 enzymes in Turkish patients with ischemic stroke
2018 · Aysun Türkanoğlu Özçelik, Tuğçe Öner, et al. · Neurological Research · 13
Characterization and modulation by drugs of sheep liver microsomal flavin monooxygenase activity
2004 · Birsen Can Demirdöğen, Orhan Adalı · Cell Biochemistry and Function · 13
Potential role of calcifying nanoparticles in the etiology of multiple sclerosis
2019 · Birsen Can Demirdöğen · Medical Hypotheses · 10
Importance of NOS3 Genetic Polymorphisms in the Risk of Development of Ischemic Stroke in the Turkish Population
2014 · Aysun Türkanoğlu Özçelik, Birsen Can Demirdöğen, et al. · Genetic Testing and Molecular Biomarkers · 9
Association of cholesterol 7α-hydroxylase (CYP7A1) promoter polymorphism (rs3808607) and cholesterol 24S-hydroxylase (CYP46A1) intron 2 polymorphism (rs754203) with serum lipids, vitamin D levels, and multiple sclerosis risk in the Turkish population
2021 · Eda Sezer, Birsen Can Demirdöğen, et al. · Neurological Sciences · 8
Paraoxonase 1 (PON1) promoter (−107T/C) and coding region (192Q/R and 55L/M) genetic variations in pseudoexfoliation syndrome and pseudoexfoliative glaucoma risk
2019 · Birsen Can Demirdöğen, Canan Koçan Akçin, et al. · Graefe s Archive for Clinical and Experimental Ophthalmology · 8
Association of cytochrome P4502E1 and NAD(P)H:quinone oxidoreductase 1 genetic polymorphisms with susceptibility to large artery atherosclerotic ischemic stroke: a case–control study in the Turkish population
2017 · Aysun Türkanoğlu Özçelik, Birsen Can Demirdöğen, et al. · Neurological Sciences · 8
Theranostic potential of graphene quantum dots for multiple sclerosis
2022 · Birsen Can Demirdöğen · Multiple Sclerosis and Related Disorders · 7
Works count: 48
Citation count: 779
H-index: 16
I10-index: 20
Year
Topic
Type